دنبال کردن
J Timothy Greenamyre
J Timothy Greenamyre
Director, Pittsburgh Institute for Neurodegenerative Diseases, Professor of Neurology
ایمیل تأیید شده در pitt.edu - صفحهٔ اصلی
عنوان
نقل شده توسط
نقل شده توسط
سال
Chronic systemic pesticide exposure reproduces features of Parkinson's disease‏
R Betarbet, TB Sherer, G MacKenzie, M Garcia-Osuna, AV Panov, ...‏
Nature neuroscience 3 (12), 1301-1306, 2000‏
47492000
Mechanism of toxicity in rotenone models of Parkinson's disease‏
TB Sherer, R Betarbet, CM Testa, BB Seo, JR Richardson, JH Kim, ...‏
Journal of Neuroscience 23 (34), 10756-10764, 2003‏
12742003
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines‏
AV Panov, CA Gutekunst, BR Leavitt, MR Hayden, JR Burke, ...‏
Nature neuroscience 5 (8), 731-736, 2002‏
12742002
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation‏
TB Sherer, JH Kim, R Betarbet, JT Greenamyre‏
Experimental neurology 179 (1), 9-16, 2003‏
10002003
A highly reproducible rotenone model of Parkinson's disease‏
JR Cannon, V Tapias, HM Na, AS Honick, RE Drolet, JT Greenamyre‏
Neurobiology of disease 34 (2), 279-290, 2009‏
9172009
Animal models of Parkinson's disease‏
R Betarbet, TB Sherer, JT Greenamyre‏
Bioessays 24 (4), 308-318, 2002‏
8392002
Alternative excitotoxic hypotheses‏
RL Albin, JT Greenamyre‏
Neurology 42 (4), 733-733, 1992‏
7821992
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage‏
TB Sherer, R Betarbet, AK Stout, S Lund, M Baptista, AV Panov, ...‏
Journal of Neuroscience 22 (16), 7006-7015, 2002‏
7522002
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease‏
R Di Maio, PJ Barrett, EK Hoffman, CW Barrett, A Zharikov, A Borah, X Hu, ...‏
Science translational medicine 8 (342), 342ra78-342ra78, 2016‏
6682016
Excitatory amino acids and Alzheimer's disease‏
JT Greenamyre, AB Young‏
Neurobiology of aging 10 (5), 593-602, 1989‏
6521989
Parkinson's--divergent causes, convergent mechanisms‏
JT Greenamyre, TG Hastings‏
Science 304 (5674), 1120-1122, 2004‏
5802004
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease‏
Huntington Study Group‏
Neurology 57 (3), 397-404, 2001‏
5132001
The role of environmental exposures in neurodegeneration and neurodegenerative diseases‏
JR Cannon, JT Greenamyre‏
Toxicological Sciences 124 (2), 225-250, 2011‏
5092011
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking‏
AL Orr, S Li, CE Wang, H Li, J Wang, J Rong, X Xu, PG Mastroberardino, ...‏
Journal of Neuroscience 28 (11), 2783-2792, 2008‏
5022008
NMDA receptor losses in putamen from patients with Huntington's disease‏
AB Young, JT Greenamyre, Z Hollingsworth, R Albin, C D'Amato, ...‏
Science 241 (4868), 981-983, 1988‏
5001988
LRRK2 activation in idiopathic Parkinson’s disease‏
R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ...‏
Science translational medicine 10 (451), eaar5429, 2018‏
4922018
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives‏
AHV Schapira, CW Olanow, JT Greenamyre, E Bezard‏
The Lancet 384 (9942), 545-555, 2014‏
4782014
Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-and kainate-sensitive glutamate binding sites.‏
JT Greenamyre, JM Olson, JB Penney, AB Young‏
The Journal of pharmacology and experimental therapeutics 233 (1), 254-263, 1985‏
4611985
Glutamate and Parkinson’s disease‏
F Blandini, RHP Porter, JT Greenamyre‏
Molecular neurobiology 12, 73-94, 1996‏
4561996
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion‏
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...‏
Neurology 78 (10), 690-695, 2012‏
4542012
سیستم در حال حاضر قادر به انجام عملکرد نیست. بعداً دوباره امتحان کنید.
مقاله‌ها 1–20